Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CCL5 Protein (AA 24-91) (His tag)

CCL5 Origine: Humain Hôte: Escherichia coli (E. coli) Recombinant >98 % (SDS-PAGE)
N° du produit ABIN7278706
  • Antigène Voir toutes CCL5 Protéines
    CCL5 (Chemokine (C-C Motif) Ligand 5 (CCL5))
    Type de proteíne
    Recombinant
    Attributs du protein
    AA 24-91
    Origine
    • 22
    • 6
    • 5
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Humain
    Source
    • 32
    • 8
    • 3
    • 2
    • 1
    • 1
    • 1
    Escherichia coli (E. coli)
    Purification/Conjugué
    Cette CCL5 protéine est marqué à la His tag.
    Fonction
    CCL5 (human) (rec.) (His)
    Specificité
    Human CCL5 (aa 24-91) is fused at the C-terminus to a His-tag.
    Attributs du produit
    Protein. Human CCL5 (aa 24-91) is fused at the C-terminus to a His-tag. Source: E. coli. Endotoxin content: <0.1EU/μg protein (LAL test, Lonza). Lyophilized from 0.2μm-filtered solution in PBS (  pH 7.4). Purity: >98 % (SDS-PAGE). CCL5, also known as RANTES (Regulated upon Activation Normal T cell Expressed and Secreted), is an 8  kDa beta-chemokine that plays a primary role in the inflammatory immune response by means of its ability to attract and activate leukocytes. Human and mouse RANTES exhibit cross-species activity on human and mouse cells. CCL5 is secreted by many cell types at inflammatory sites and it exerts a wide range of activities through the receptors CCR1, CCR3, CCR4 and CCR5. In humans, CCR5 binding to CCL5 inhibits the infectivity of R5 (M-tropic) but not X4 (T-tropic) strains of HIV-1. The deposition of CCL5 on activated vascular endothelial cells is crucial for monocyte adhesion to damaged vasculature, but CCL5 oligomerization is not required for the extravasation of adherent leukocytes. CCL5 is upregulated in breast cancer and promotes tumor progression through the attraction of proinflammatory macrophages in addition to its actions on tumor cells, stromal cells and the vasculature.
    Pureté
    >98 % (SDS-PAGE)
    niveau d'endotoxine
    <0.1EU/μg protein (LAL test, Lonza).
    Top Product
    Discover our top product CCL5 Protéine
  • Restrictions
    For Research Use only
  • Format
    Lyophilized
    Concentration
    Lot specific
    Buffer
    Lyophilized from 0.2μm-filtered solution in PBS (  pH 7.4).
    Conseil sur la manipulation
    Avoid freeze/thaw cycles.
    Stock
    4 °C,-20 °C
    Stockage commentaire

    Short Term Storage: +4°C

    Long Term Storage: -20°C

    Use & Stability: Stable for at least 1 year after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C.

  • Antigène
    CCL5 (Chemokine (C-C Motif) Ligand 5 (CCL5))
    Autre désignation
    CCL5 (CCL5 Produits)
    Synonymes
    Rantes Protein, Scya5 Protein, D17S136E Protein, RANTES Protein, SCYA5 Protein, SIS-delta Protein, SISd Protein, TCP228 Protein, eoCP Protein, MuRantes Protein, C-C motif chemokine 5-like Protein, C-C motif chemokine ligand 5 Protein, chemokine (C-C motif) ligand 5 Protein, LOC100230935 Protein, CCL5 Protein, Ccl5 Protein
    Sujet

    Alternate Names/Synonyms: C-C Motif Chemokine 5, Eosinophil Chemotactic Cytokine, EoCP, Small-inducible Cytokine A5, T Cell-specific Protein P228, TCP228, T Cell-specific Protein RANTES

    Product Description: CCL5, also known as RANTES (Regulated upon Activation Normal T cell Expressed and Secreted), is an 8  kDa beta-chemokine that plays a primary role in the inflammatory immune response by means of its ability to attract and activate leukocytes. Human and mouse RANTES exhibit cross-species activity on human and mouse cells. CCL5 is secreted by many cell types at inflammatory sites and it exerts a wide range of activities through the receptors CCR1, CCR3, CCR4 and CCR5. In humans, CCR5 binding to CCL5 inhibits the infectivity of R5 (M-tropic) but not X4 (T-tropic) strains of HIV-1. The deposition of CCL5 on activated vascular endothelial cells is crucial for monocyte adhesion to damaged vasculature, but CCL5 oligomerization is not required for the extravasation of adherent leukocytes. CCL5 is upregulated in breast cancer and promotes tumor progression through the attraction of proinflammatory macrophages in addition to its actions on tumor cells, stromal cells and the vasculature.

    Pathways
    Cellular Response to Molecule of Bacterial Origin, Regulation of G-Protein Coupled Receptor Protein Signaling, Smooth Muscle Cell Migration
Vous êtes ici:
Support technique